Cargando…
Evolution in Real-World Therapeutic Strategies for HIV Treatment: A Retrospective Study in Southern Italy, 2014–2020
Changes in HIV treatment guidelines over the last two decades reflect the evolving challenges in this field. Our study examined treatment change patterns throughout a 7-year period in a large Italian cohort of HIV patients as well as the reasons and direction of changes. Treatment-naïve and -experie...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745745/ https://www.ncbi.nlm.nih.gov/pubmed/35011902 http://dx.doi.org/10.3390/jcm11010161 |
_version_ | 1784630419931529216 |
---|---|
author | Papa, Nunzia Cammarota, Simona Citarella, Anna Atripaldi, Luigi Bernardi, Francesca F. Fogliasecca, Marianna Giugliano, Nello Trama, Ugo Spatarella, Micaela |
author_facet | Papa, Nunzia Cammarota, Simona Citarella, Anna Atripaldi, Luigi Bernardi, Francesca F. Fogliasecca, Marianna Giugliano, Nello Trama, Ugo Spatarella, Micaela |
author_sort | Papa, Nunzia |
collection | PubMed |
description | Changes in HIV treatment guidelines over the last two decades reflect the evolving challenges in this field. Our study examined treatment change patterns throughout a 7-year period in a large Italian cohort of HIV patients as well as the reasons and direction of changes. Treatment-naïve and -experienced HIV patients managed by Cotugno Hospital of Naples between 2014 and 2020 were analyzed. During the period, the proportion of single-tablet regimen treatment sharply increased for the naïve and experienced patients. Regimens containing integrase strand transfer inhibitors rapidly replaced those containing protease inhibitor and non-nucleoside reverse transcriptase inhibitors. The use of the tenofovir alafenamide fumarate/emtricitabine backbone increased rapidly after its introduction in the Italian pharmaceutical market, making up 63.7 and 54.9% of all treatments in naïve and experienced patients, respectively, in 2020. The main reason for treatment changes was optimization and/or simplification (90.6% in 2018; 85.3% in 2019; 95.5 in 2020) followed by adverse effects and virological failure. Our real-world analysis revealed that the majority of treatment-naïve and treatment-experienced patients received antiretroviral drugs listed as preferred/recommended in current recommendations. Regimen optimization and/or simplification is a leading cause of treatment modification, while virologic failure or adverse effects are less likely reasons for modification in the current treatment landscape. |
format | Online Article Text |
id | pubmed-8745745 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87457452022-01-11 Evolution in Real-World Therapeutic Strategies for HIV Treatment: A Retrospective Study in Southern Italy, 2014–2020 Papa, Nunzia Cammarota, Simona Citarella, Anna Atripaldi, Luigi Bernardi, Francesca F. Fogliasecca, Marianna Giugliano, Nello Trama, Ugo Spatarella, Micaela J Clin Med Article Changes in HIV treatment guidelines over the last two decades reflect the evolving challenges in this field. Our study examined treatment change patterns throughout a 7-year period in a large Italian cohort of HIV patients as well as the reasons and direction of changes. Treatment-naïve and -experienced HIV patients managed by Cotugno Hospital of Naples between 2014 and 2020 were analyzed. During the period, the proportion of single-tablet regimen treatment sharply increased for the naïve and experienced patients. Regimens containing integrase strand transfer inhibitors rapidly replaced those containing protease inhibitor and non-nucleoside reverse transcriptase inhibitors. The use of the tenofovir alafenamide fumarate/emtricitabine backbone increased rapidly after its introduction in the Italian pharmaceutical market, making up 63.7 and 54.9% of all treatments in naïve and experienced patients, respectively, in 2020. The main reason for treatment changes was optimization and/or simplification (90.6% in 2018; 85.3% in 2019; 95.5 in 2020) followed by adverse effects and virological failure. Our real-world analysis revealed that the majority of treatment-naïve and treatment-experienced patients received antiretroviral drugs listed as preferred/recommended in current recommendations. Regimen optimization and/or simplification is a leading cause of treatment modification, while virologic failure or adverse effects are less likely reasons for modification in the current treatment landscape. MDPI 2021-12-29 /pmc/articles/PMC8745745/ /pubmed/35011902 http://dx.doi.org/10.3390/jcm11010161 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Papa, Nunzia Cammarota, Simona Citarella, Anna Atripaldi, Luigi Bernardi, Francesca F. Fogliasecca, Marianna Giugliano, Nello Trama, Ugo Spatarella, Micaela Evolution in Real-World Therapeutic Strategies for HIV Treatment: A Retrospective Study in Southern Italy, 2014–2020 |
title | Evolution in Real-World Therapeutic Strategies for HIV Treatment: A Retrospective Study in Southern Italy, 2014–2020 |
title_full | Evolution in Real-World Therapeutic Strategies for HIV Treatment: A Retrospective Study in Southern Italy, 2014–2020 |
title_fullStr | Evolution in Real-World Therapeutic Strategies for HIV Treatment: A Retrospective Study in Southern Italy, 2014–2020 |
title_full_unstemmed | Evolution in Real-World Therapeutic Strategies for HIV Treatment: A Retrospective Study in Southern Italy, 2014–2020 |
title_short | Evolution in Real-World Therapeutic Strategies for HIV Treatment: A Retrospective Study in Southern Italy, 2014–2020 |
title_sort | evolution in real-world therapeutic strategies for hiv treatment: a retrospective study in southern italy, 2014–2020 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745745/ https://www.ncbi.nlm.nih.gov/pubmed/35011902 http://dx.doi.org/10.3390/jcm11010161 |
work_keys_str_mv | AT papanunzia evolutioninrealworldtherapeuticstrategiesforhivtreatmentaretrospectivestudyinsouthernitaly20142020 AT cammarotasimona evolutioninrealworldtherapeuticstrategiesforhivtreatmentaretrospectivestudyinsouthernitaly20142020 AT citarellaanna evolutioninrealworldtherapeuticstrategiesforhivtreatmentaretrospectivestudyinsouthernitaly20142020 AT atripaldiluigi evolutioninrealworldtherapeuticstrategiesforhivtreatmentaretrospectivestudyinsouthernitaly20142020 AT bernardifrancescaf evolutioninrealworldtherapeuticstrategiesforhivtreatmentaretrospectivestudyinsouthernitaly20142020 AT fogliaseccamarianna evolutioninrealworldtherapeuticstrategiesforhivtreatmentaretrospectivestudyinsouthernitaly20142020 AT giuglianonello evolutioninrealworldtherapeuticstrategiesforhivtreatmentaretrospectivestudyinsouthernitaly20142020 AT tramaugo evolutioninrealworldtherapeuticstrategiesforhivtreatmentaretrospectivestudyinsouthernitaly20142020 AT spatarellamicaela evolutioninrealworldtherapeuticstrategiesforhivtreatmentaretrospectivestudyinsouthernitaly20142020 |